ORBIMED ADVISORS LLC purchased 950K shares of ADARX PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $16.15M. The strongest form of insider conviction signal.
Common Stock
Shares
+10.69M
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+2M
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+769.60K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+564.19K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+300.25K
Price / share
$17.00
Trade value
$5.10M
% of position
Common Stock
Shares
+7.13M
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+1.33M
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+513.07K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+256.45K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+61.52K
Price / share
$17.00
Trade value
$1.05M
% of position
Common Stock
Shares
+588.24K
Price / share
$17.00
Trade value
$10M
% of position
Net shares
+24.21M
Net value
$16.15M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/28/2026 | C · Conversion | +10.69M | — | — | New position | 0.00 | 10.69M |
| Common Stock Indirect | 9/28/2026 | C · Conversion | +2M | — | — | 18.7% | 10.69M | 12.69M |
| Common Stock Indirect | 9/28/2026 | C · Conversion | +769.60K | — | — | 6.1% | 12.69M | 13.46M |
| Common Stock Indirect | 9/28/2026 | C · Conversion | +564.19K | — | — | 4.2% | 13.46M | 14.03M |
| Common Stock Indirect | 9/28/2026 | P · Purchase | +300.25K | $17.00 | $5.10M | 2.1% | 14.03M | 14.33M |
| Common Stock Indirect | 9/28/2026 | C · Conversion | +7.13M | — | — | New position | 0.00 | 7.13M |
| Common Stock Indirect | 9/28/2026 | C · Conversion | +1.33M | — | — | 18.7% | 7.13M | 8.46M |
| Common Stock Indirect | 9/28/2026 | C · Conversion | +513.07K | — | — | 6.1% | 8.46M | 8.97M |
| Common Stock Indirect | 9/28/2026 | C · Conversion | +256.45K | — | — | 2.9% | 8.97M | 9.23M |
| Common Stock Indirect | 9/28/2026 | P · Purchase | +61.52K | $17.00 | $1.05M | 0.7% | 9.23M | 9.29M |
| Common Stock Indirect | 9/28/2026 | P · Purchase | +588.24K | $17.00 | $10M | New position | 0.00 | 588.24K |
| Total | +24.21M | $16.15M | ||||||
Series A Preferred Stock
Common Stock
10.69M shares
Shares
−10.69M
Strike price
Held after
0.00
Exercisable
—
Series B Preferred Stock
Common Stock
2M shares
Shares
−2M
Strike price
Held after
0.00
Exercisable
—
Series B-1 Preferred Stock
Common Stock
769.60K shares
Shares
−769.60K
Strike price
Held after
0.00
Exercisable
—
Series C Preferred Stock
Common Stock
564.19K shares
Shares
−564.19K
Strike price
Held after
0.00
Exercisable
—
Series A Preferred Stock
Common Stock
7.13M shares
Shares
−7.13M
Strike price
Held after
0.00
Exercisable
—
Series B Preferred Stock
Common Stock
1.33M shares
Shares
−1.33M
Strike price
Held after
0.00
Exercisable
—
Series B-1 Preferred Stock
Common Stock
513.07K shares
Shares
−513.07K
Strike price
Held after
0.00
Exercisable
—
Series C Preferred Stock
Common Stock
256.45K shares
Shares
−256.45K
Strike price
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A Preferred Stock Indirect | Common Stock10.69M shares | 9/28/2026 | C · Conversion | −10.69M | — | 0.00 | |
| Series B Preferred Stock Indirect | Common Stock2M shares | 9/28/2026 | C · Conversion | −2M | — | 0.00 | |
| Series B-1 Preferred Stock Indirect | Common Stock769.60K shares | 9/28/2026 | C · Conversion | −769.60K | — | 0.00 | |
| Series C Preferred Stock Indirect | Common Stock564.19K shares | 9/28/2026 | C · Conversion | −564.19K | — | 0.00 | |
| Series A Preferred Stock Indirect | Common Stock7.13M shares | 9/28/2026 | C · Conversion | −7.13M | — | 0.00 | |
| Series B Preferred Stock Indirect | Common Stock1.33M shares | 9/28/2026 | C · Conversion | −1.33M | — | 0.00 | |
| Series B-1 Preferred Stock Indirect | Common Stock513.07K shares | 9/28/2026 | C · Conversion | −513.07K | — | 0.00 | |
| Series C Preferred Stock Indirect | Common Stock256.45K shares | 9/28/2026 | C · Conversion | −256.45K | — | 0.00 |